Recent Publications

Lantum HBM, Iyer RA, and Anders MW. (2004) Acivicin-induced alterations in renal and hepatic glutathione concentrations and in g-glutamyltransferase activities. Biochem. Pharmacol. 67, 1421-1426.

Anderson WB, Board PG, and Anders, MW. (2004) Glutathione transferase zeta-catalyzed bioactivation of dichloroacetic acid: reaction of glyoxylate with amino acid nucleophiles. Chem. Res. Toxicol. 17, 650-662.

Xu L, Krenitsky DM, Seacat AM, Butenhoff JL, and Anders MW. (2004) Biotransformation of N-ethyl-N-(2-hydroxyethyl)perfluorosulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450. Chem. Res. Toxicol. 17, 767-775.

Lim C, Matthaei KI, Blackburn AC, Davis R, Dahlstrom JE, Koina M, Anders MW, and Board PG. (2004) Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of mu and pi class glutathione transferases. Am. J. Pathol. 165, 679-693.

Xu L, Krenitsky DM, Seacat AM, Butenhoff JL, Tephly TR, and Anders MW. (2004) Biotransformation of N-ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450.
Chem. Res. Toxicol. 17:767-775.

Board PG and Anders MW  (2005)  Human glutathione transferase zeta.  Methods Enzymol. 401:61-77.

Anders MW, Robotham JL, and Sheu SS  (2006)  Mitochondria: new drug targets for oxidative stress-induced diseases.  Expert Opin. Drug Metab. Toxicol. 2:71-79.

Blackburn AC, Matthaei KI, Lim C, Taylor MC, Cappello JY, Hayes JD, Anders MW, and Board PG  (2006)  Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways.  Mol. Pharmacol. 69:650-657.

Fang YY, Kashkarov U, Anders MW, and Board PG  (2006)  Polymorphisms in the human glutathione transferase zeta promoter.  Pharmacogenet. Genomics 16:307-313.

Sheu SS, Nauduri D, and Anders MW  (2006)  Targeting antioxidants to mitochondria:  a new therapeutic direction.  Biochim. Biophys. Acta 1762:256-265.

Starr TB, Matanoski G, Anders MW, and Andersen ME  (2006)  Workshop overview: reassessment of the cancer risk of dichloromethane in humans.  Toxicol. Sci. 91:20-28.

Xu L, Krenitsky DM, Seacat, AM, Butenhoff JL, Tephly .TR, and Anders MW  (2006)  N-Glucuronidation of perfluorooctanesulfonamide by human, rat, dog, and monkey liver microsomes and by expressed rat and human UDP-glucuronosyltransferases.  Drug Metab.Dispos., in press.